Neurocrine Biosciences, Inc. (0K6R.L)

USD 138.27

(1.59%)

Eps Summary of Neurocrine Biosciences, Inc.

  • Neurocrine Biosciences, Inc.'s latest annual eps in 2023 was 2.56 USD , up 59.01% from previous year.
  • Neurocrine Biosciences, Inc.'s latest quarterly eps in 2024 Q3 was 1.28 USD , up 100.0% from previous quarter.
  • Neurocrine Biosciences, Inc. reported an annual eps of 1.61 USD in 2022, up 69.47% from previous year.
  • Neurocrine Biosciences, Inc. reported an annual eps of 0.95 USD in 2021, down -78.26% from previous year.
  • Neurocrine Biosciences, Inc. reported a quarterly eps of 0.43 USD for 2024 Q1, down -71.33% from previous quarter.
  • Neurocrine Biosciences, Inc. reported a quarterly eps of 0.64 USD for 2024 Q2, up 48.84% from previous quarter.

Annual Eps Chart of Neurocrine Biosciences, Inc. (2023 - 1996)

Historical Annual Eps of Neurocrine Biosciences, Inc. (2023 - 1996)

Year Eps Eps Growth
2023 2.56 USD 59.01%
2022 1.61 USD 69.47%
2021 0.95 USD -78.26%
2020 4.37 USD 992.5%
2019 0.40 USD 81.82%
2018 0.22 USD 113.58%
2017 -1.62 USD 0.61%
2016 -1.63 USD -55.24%
2015 -1.05 USD -29.63%
2014 -0.81 USD -17.39%
2013 -0.69 USD -1000.78%
2012 0.08 USD -88.74%
2011 0.68 USD 553.33%
2010 -0.15 USD 88.46%
2009 -1.30 USD 43.48%
2008 -2.30 USD 57.8%
2007 -5.45 USD -91.9%
2006 -2.84 USD -373.33%
2005 -0.60 USD 52.38%
2004 -1.26 USD -35.48%
2003 -0.93 USD 70.0%
2002 -3.10 USD -118.31%
2001 -1.42 USD -9.23%
2000 -1.30 USD -47.73%
1999 -0.88 USD 20.0%
1998 -1.10 USD -466.67%
1997 0.30 USD -23.08%
1996 0.39 USD 0.0%

Peer Eps Comparison of Neurocrine Biosciences, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD 226.733%
Dynavax Technologies Corporation -0.05 USD 5261.29%
Supernus Pharmaceuticals, Inc. 0.02 USD -10522.407%
Perrigo Company plc -0.09 USD 2826.305%
Illumina, Inc. -7.35 USD 134.83%
Thermo Fisher Scientific Inc. 15.53 USD 83.516%
Iovance Biotherapeutics, Inc. -1.89 USD 235.45%
Walgreens Boots Alliance, Inc. -10.01 USD 125.574%
IQVIA Holdings Inc. 7.39 USD 65.359%
Heron Therapeutics, Inc. -0.80 USD 420.0%
Regeneron Pharmaceuticals, Inc. 37.05 USD 93.09%
Unity Biotechnology, Inc. -2.70 USD 194.815%
Waters Corporation 10.87 USD 76.449%
Biogen Inc. 8.02 USD 68.08%
Sangamo Therapeutics, Inc. -1.48 USD 272.973%
Evolus, Inc. -1.08 USD 337.037%
Adicet Bio, Inc. -3.31 USD 177.341%
Cara Therapeutics, Inc. -2.19 USD 216.895%
bluebird bio, Inc. -1.93 USD 232.642%
Esperion Therapeutics, Inc. -2.03 USD 226.108%
FibroGen, Inc. -2.92 USD 187.671%
Agilent Technologies, Inc. 4.22 USD 39.336%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 124.83%
Homology Medicines, Inc. -7.41 USD 134.548%
Geron Corporation -0.32 USD 900.0%
Alnylam Pharmaceuticals, Inc. -3.52 USD 172.727%
Amicus Therapeutics, Inc. -0.51 USD 601.961%
Myriad Genetics, Inc. -1.39 USD 284.173%
Viking Therapeutics, Inc. -0.91 USD 381.319%
Intellia Therapeutics, Inc. -5.42 USD 147.232%
Zoetis Inc. 5.08 USD 49.606%
Abeona Therapeutics Inc. -2.53 USD 201.186%
Mettler-Toledo International Inc. 36.10 USD 92.909%
BioMarin Pharmaceutical Inc. 0.89 USD -187.64%
Vertex Pharmaceuticals Incorporated 14.05 USD 81.779%
Kala Pharmaceuticals, Inc. -17.35 USD 114.755%
Ionis Pharmaceuticals, Inc. -2.56 USD 200.0%
Atara Biotherapeutics, Inc. -65.18 USD 103.928%
Verastem, Inc. -3.96 USD 164.646%
Nektar Therapeutics -1.45 USD 276.552%
Axsome Therapeutics, Inc. -5.27 USD 148.577%
Aclaris Therapeutics, Inc. -1.27 USD 301.575%
Sarepta Therapeutics, Inc. -5.80 USD 144.138%
OPKO Health, Inc. -0.25 USD 1124.0%
Exelixis, Inc. 0.65 USD -293.846%
Corcept Therapeutics Incorporated 1.02 USD -150.98%
Anavex Life Sciences Corp. -0.60 USD 526.667%
uniQure N.V. -6.47 USD 139.567%
Imunon, Inc. -2.16 USD 218.519%
Blueprint Medicines Corporation -8.37 USD 130.585%
Insmed Incorporated -5.34 USD 147.94%
Halozyme Therapeutics, Inc. 2.13 USD -20.188%
Agios Pharmaceuticals, Inc. -6.33 USD 140.442%
TG Therapeutics, Inc. 0.09 USD -2766.741%
Incyte Corporation 2.67 USD 4.12%
Emergent BioSolutions Inc. -14.85 USD 117.239%